CA3243267A1 - SUBSTITUTE PIPERIDIN COMPOUND CRYSTAL, SUBSTITUTE PIPERIDIN COMPOUND SALTS AND CORRESPONDING CRYSTALS - Google Patents

SUBSTITUTE PIPERIDIN COMPOUND CRYSTAL, SUBSTITUTE PIPERIDIN COMPOUND SALTS AND CORRESPONDING CRYSTALS

Info

Publication number
CA3243267A1
CA3243267A1 CA3243267A CA3243267A CA3243267A1 CA 3243267 A1 CA3243267 A1 CA 3243267A1 CA 3243267 A CA3243267 A CA 3243267A CA 3243267 A CA3243267 A CA 3243267A CA 3243267 A1 CA3243267 A1 CA 3243267A1
Authority
CA
Canada
Prior art keywords
crystal
ppm
azabicyclo
methoxypiperidin
fluoropyrimidin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3243267A
Other languages
English (en)
French (fr)
Inventor
Ikuo Kushida
Yoko Ito
So Yasui
Takashi Fukuyama
Nobuaki Sato
Taro ASABA
Original Assignee
Eisai R&D Management Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Management Co Ltd filed Critical Eisai R&D Management Co Ltd
Publication of CA3243267A1 publication Critical patent/CA3243267A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
CA3243267A 2022-01-14 2023-01-12 SUBSTITUTE PIPERIDIN COMPOUND CRYSTAL, SUBSTITUTE PIPERIDIN COMPOUND SALTS AND CORRESPONDING CRYSTALS Pending CA3243267A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2022-004608 2022-01-14
JP2022004608 2022-01-14
PCT/JP2023/000561 WO2023136279A1 (ja) 2022-01-14 2023-01-12 置換ピペリジン化合物の結晶並びに置換ピペリジン化合物の塩及びそれらの結晶

Publications (1)

Publication Number Publication Date
CA3243267A1 true CA3243267A1 (en) 2025-04-10

Family

ID=87279104

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3243267A Pending CA3243267A1 (en) 2022-01-14 2023-01-12 SUBSTITUTE PIPERIDIN COMPOUND CRYSTAL, SUBSTITUTE PIPERIDIN COMPOUND SALTS AND CORRESPONDING CRYSTALS

Country Status (10)

Country Link
US (1) US20250051322A1 (https=)
EP (1) EP4438602A4 (https=)
JP (1) JPWO2023136279A1 (https=)
KR (1) KR20240134870A (https=)
CN (1) CN118451076A (https=)
AU (1) AU2023206823A1 (https=)
CA (1) CA3243267A1 (https=)
MX (1) MX2024008024A (https=)
TW (1) TW202334120A (https=)
WO (1) WO2023136279A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7591592B2 (ja) * 2022-01-14 2024-11-28 エーザイ・アール・アンド・ディー・マネジメント株式会社 置換ピペリジン化合物を含有する医薬

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG34208A1 (en) 1995-03-01 1996-12-06 Guy Andrew Vaz Blast and fragment resistant polyurethane boot sole for safety footwear
EP0828751A4 (en) 1995-05-05 1999-01-20 Human Genome Sciences Inc HUMAN NEUROPEPTIDE RECEPTOR
US6309854B1 (en) 1996-12-17 2001-10-30 Smithkline Beecham Corporation Polynucleotides encoding ligands of the neuropeptide receptor HFGAN72
US6159605A (en) 1997-02-18 2000-12-12 Dainichiseika Color & Chemicals Mfg. Co., Ltd. Ink-jet recording sheet
US5935814A (en) 1997-04-30 1999-08-10 Smithkline Beecham Corporation Polynucleotides encoding HFGAN72Y receptor
US6020157A (en) 1997-04-30 2000-02-01 Smithkline Beecham Corporation Polynucleotides encoding HFGAN72X receptor
US6166193A (en) 1997-07-25 2000-12-26 Board Of Regents, University Of Texas System Polynucleotides encoding MY1 receptor
KR100327888B1 (ko) 1999-07-14 2002-03-09 정숭렬 도로포장 파손촉진 시험장치의 무선제어 시스템
TW201444849A (zh) * 2013-03-13 2014-12-01 Janssen Pharmaceutica Nv 經取代的7-氮雜雙環類及其作為食慾激素受體調節劑之用途
EP3896060B1 (en) * 2018-12-12 2023-08-16 Takeda Pharmaceutical Company Limited Heterocyclic compound
TWI888599B (zh) * 2020-07-17 2025-07-01 日商衛材R&D企管股份有限公司 取代哌啶化合物及其用途

Also Published As

Publication number Publication date
CN118451076A (zh) 2024-08-06
EP4438602A1 (en) 2024-10-02
TW202334120A (zh) 2023-09-01
US20250051322A1 (en) 2025-02-13
KR20240134870A (ko) 2024-09-10
WO2023136279A1 (ja) 2023-07-20
AU2023206823A1 (en) 2024-07-11
MX2024008024A (es) 2024-07-15
JPWO2023136279A1 (https=) 2023-07-20
EP4438602A4 (en) 2025-11-19

Similar Documents

Publication Publication Date Title
US11479552B2 (en) Substituted piperidine compounds and their use
ES3034158T3 (en) Novel salt of terphenyl compound
EA035534B1 (ru) Соли ингибитора lsd1
US20250051322A1 (en) Crystal of substituted piperidine compound, salts of substituted piperidine compound, and crystals thereof
JP3701964B1 (ja) キヌクリジン誘導体の新規な塩
CN114728982A (zh) 固体形式的s1p-受体调节剂
RU2840772C1 (ru) Замещенные пиперидиновые соединения и их применение
JP7591592B2 (ja) 置換ピペリジン化合物を含有する医薬
TWI922338B (zh) 取代哌啶化合物及其用途
EA045865B1 (ru) Замещенные пиперидиновые соединения и их применение
US20250230148A1 (en) Crystal of fused tricyclic derivative or pharmaceutically acceptable salt thereof
HK40083601A (en) Substituted piperidine compound and application thereof
JP4614084B2 (ja) キヌクリジン誘導体含有医薬組成物
WO2025185704A1 (zh) 一种kif18a抑制剂的晶型及其制备方法和应用
JP2007332032A (ja) 医薬結晶化合物

Legal Events

Date Code Title Description
A00 Application filed

Free format text: ST27 STATUS EVENT CODE: A-1-1-A10-A00-A102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: COMPLIANCE REQUIREMENTS DETERMINED MET

Effective date: 20240806

A15 Pct application entered into the national or regional phase

Free format text: ST27 STATUS EVENT CODE: A-1-1-A10-A15-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: NATIONAL ENTRY REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20240806

P18 Priority claim added or amended

Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P18-P105 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: PRIORITY CLAIM REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20240806

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20240820

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST TO REGISTER A DOCUMENT RECEIVED

Effective date: 20240820

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REGISTER A DOCUMENT REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20240826

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20241003

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 2ND ANNIV.) - STANDARD

Year of fee payment: 2

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20241204

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20241206

Q12 Application published

Free format text: ST27 STATUS EVENT CODE: A-1-1-Q10-Q12-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION PUBLISHED (OPEN TO PUBLIC INSPECTION)

Effective date: 20250410

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD

Year of fee payment: 3

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20260105

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20260105